Ann: Update - AnteoTech signs manufacturing contract with Operon, page-21

if you read that announcement, you could see why we needed extra money pretty much immediately. so much is happening. it's brilliant!!!!

- 8m complete tests added to Ellumes revenue would more than justify our current m/cap
- extra 12m lateral flow strips. do you think we are producing these without another manufacture lined up to complete the test. this would, when sold double our current m/cap imo
-hinted at our developing relationships in the lateral flow manufacturing sector will bring manufacturing capability online for the entire suite of EuGeni tests. more manufacturing ann's to come!!!
-enchancing QMS and MDSAP accreditations
- saliva use trial finishing in June
-1st sale completed
-appointed representatives in France and india, and similar arrangements in process in UK and Germany
-validation studies currently being conducted in India and France